藥物溶離度測試服務市場－全球產業規模、佔有率、趨勢、機會及預測（按服務方法、溶離度儀器、劑型、地區及競爭細分，2020-2030 年）

2024 年全球藥品溶離度測試服務市值為 7.0234 億美元，預計到 2030 年將達到 11.3414 億美元，預測期內複合年成長率為 8.31%。由於製藥業優先考慮藥品品質、法規遵循度和治療效果，對溶離度測試服務的需求正在上升。這些服務對於藥物開發和品質控制至關重要，可以深入了解固體劑型的溶解速率、生物利用度和體內性能。溶解測試模擬藥物在體內的釋放，幫助製造商確保一致性、安全性和治療效果。日益嚴格的全球監管架構使得溶離度測試成為強制性標準，進一步推動了市場需求。透過持續監測藥物溶解情況，製藥公司可以改進配方和製造程序，從而提高產品可靠性。隨著越來越複雜和創新的藥物配方進入開發階段，溶離度測試服務在支援監管提交和批次間一致性方面變得不可或缺，使其成為藥物研發和品質保證的關鍵組成部分。

關鍵市場促進因素

新興醫藥研發

主要市場挑戰

監理合規

主要市場趨勢

增加藥物開發活動

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球藥物溶離度測試服務市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依服務方法（體外、體內）
  • 按溶離度儀（籃式、槳式、其他）
  • 按劑型（膠囊、錠劑、其他）
  • 按公司分類（2024）
  • 按地區
• 市場地圖

第6章：北美藥物溶離度測試服務市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第7章：歐洲藥物溶離度測試服務市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區藥物溶離度測試服務市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲

第9章：南美洲藥物溶離度測試服務市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東和非洲藥品溶離度測試服務市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 產品發布
• 併購

第 13 章： 大環境分析

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章：競爭格局

• Intertek Group Plc
• Avivia BV
• Almac Group
• Agilent Technologies, Inc.
• Catalent, Inc.
• Thermofisher Scientific Inc.
• Charles River Laboratories
• Cambrex
• Boston Analytical
• Pace Analytical Life Sciences

第 16 章：策略建議

第17章調查會社について,免責事項

The Global Pharmaceutical Dissolution Testing Services Market was valued at USD 702.34 Million in 2024 and is projected to reach USD 1134.14 Million by 2030, growing at a CAGR of 8.31% during the forecast period. As the pharmaceutical industry prioritizes drug quality, regulatory adherence, and therapeutic efficacy, the demand for dissolution testing services is on the rise. These services are vital in drug development and quality control, providing insights into the dissolution rate, bioavailability, and in vivo performance of solid dosage forms. Dissolution testing simulates the release of a drug in the body, helping manufacturers ensure consistency, safety, and therapeutic effectiveness. Increasingly stringent global regulatory frameworks have made dissolution testing a mandatory standard, further driving market demand. Through continuous monitoring of drug dissolution profiles, pharmaceutical firms can refine formulations and manufacturing processes, contributing to enhanced product reliability. As more complex and innovative drug formulations enter development, dissolution testing services are becoming indispensable in supporting regulatory submissions and batch-to-batch consistency, making them a critical component of pharmaceutical R&D and quality assurance.

Key Market Drivers

Rising Pharmaceutical R&D

The growth of pharmaceutical research and development is a key factor propelling the Global Pharmaceutical Dissolution Testing Services Market. With increasing investment in novel drug development and therapeutic innovation, the role of dissolution testing has become integral to optimizing formulations, assessing drug bioavailability, and ensuring production consistency. The surge in new drug candidates across therapeutic areas demands robust testing solutions to meet regulatory and clinical standards. According to the OECD, global pharmaceutical R&D expenditure reached USD 129 billion in 2021, with the United States contributing the majority share. This upward trend is reinforced by rapid R&D expansion in countries like China, which recorded a 189% increase in pharmaceutical research spending between 2010 and 2019. As R&D activity accelerates globally, the need for specialized testing services, particularly in dissolution studies, is rising, ensuring compliance, safety, and therapeutic performance in increasingly complex drug products.

Key Market Challenges

Regulatory Compliance

Regulatory compliance remains a significant challenge for the pharmaceutical dissolution testing services market. With evolving guidelines from global authorities such as the U.S. FDA and EMA, testing laboratories must stay updated with the latest requirements for drug evaluation. Adhering to these standards necessitates significant investment in training, advanced instrumentation, and meticulous documentation. Non-compliance can result in regulatory penalties, delays in product approvals, or product recalls, affecting a company's market standing and operational costs. As compliance expectations grow more stringent, service providers must continuously adapt their processes, ensuring accuracy, traceability, and alignment with international regulatory frameworks. The constant evolution of compliance benchmarks places a considerable operational and financial burden on testing organizations, making regulatory alignment a critical success factor in the dissolution testing services market.

Key Market Trends

Increasing Drug Development Activities

The escalating pace of drug development is driving increased demand for pharmaceutical dissolution testing services. With the pharmaceutical industry expanding its focus on targeted therapies, biologics, and controlled-release formulations, the need for precise and reliable dissolution testing is more crucial than ever. These tests play a vital role in formulation development, quality control, and regulatory approval. Modern formulations, including nanoparticles and extended-release systems, require specialized dissolution assessments to ensure accurate drug performance analysis. Regulatory agencies demand rigorous documentation of dissolution profiles during the drug approval process, reinforcing the value of expert testing services. Additionally, outsourcing testing to specialized providers offers pharmaceutical companies cost efficiency, flexibility, and access to technical expertise. This growing trend, fueled by a focus on time and resource optimization, is expected to support the sustained expansion of the dissolution testing services market.

Key Market Players

• Intertek Group Plc
• Avivia BV
• Almac Group
• Agilent Technologies, Inc.
• Catalent, Inc.
• Thermo Fisher Scientific Inc
• Charles River Laboratories
• Cambrex
• Boston Analytical
• Pace Analytical Life Sciences

Report Scope:

In this report, the Global Pharmaceutical Dissolution Testing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Dissolution Testing Services Market, By Services Method:

• In vitro
• In vivo

Pharmaceutical Dissolution Testing Services Market, By Dosage Form:

• Capsule
• Tablets
• Others

Pharmaceutical Dissolution Testing Services Market, By Dissolution Apparatus:

• Basket
• Paddle
• Others

Pharmaceutical Dissolution Testing Services Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Dissolution Testing Services Market.

Available Customizations:

Global Pharmaceutical Dissolution Testing Services market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Dissolution Testing Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Services Method (In vitro, In vivo)
  • 5.2.2. By Dissolution Apparatus (Basket, Paddle, Others)
  • 5.2.3. By Dosage Form (Capsule, Tablets, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Pharmaceutical Dissolution Testing Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Services Method
  • 6.2.2. By Dissolution Apparatus
  • 6.2.3. By Dosage Form
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pharmaceutical Dissolution Testing Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Services Method
      • 6.3.1.2.2. By Dissolution Apparatus
      • 6.3.1.2.3. By Dosage Form
  • 6.3.2. Mexico Pharmaceutical Dissolution Testing Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Services Method
      • 6.3.2.2.2. By Dissolution Apparatus
      • 6.3.2.2.3. By Dosage Form
  • 6.3.3. Canada Pharmaceutical Dissolution Testing Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Services Method
      • 6.3.3.2.2. By Dissolution Apparatus
      • 6.3.3.2.3. By Dosage Form

7. Europe Pharmaceutical Dissolution Testing Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Services Method
  • 7.2.2. By Dissolution Apparatus
  • 7.2.3. By Dosage Form
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pharmaceutical Dissolution Testing Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Services Method
      • 7.3.1.2.2. By Dissolution Apparatus
      • 7.3.1.2.3. By Dosage Form
  • 7.3.2. Germany Pharmaceutical Dissolution Testing Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Services Method
      • 7.3.2.2.2. By Dissolution Apparatus
      • 7.3.2.2.3. By Dosage Form
  • 7.3.3. United Kingdom Pharmaceutical Dissolution Testing Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Services Method
      • 7.3.3.2.2. By Dissolution Apparatus
      • 7.3.3.2.3. By Dosage Form
  • 7.3.4. Italy Pharmaceutical Dissolution Testing Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Services Method
      • 7.3.4.2.2. By Dissolution Apparatus
      • 7.3.4.2.3. By Dosage Form
  • 7.3.5. Spain Pharmaceutical Dissolution Testing Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Services Method
      • 7.3.5.2.2. By Dissolution Apparatus
      • 7.3.5.2.3. By Dosage Form

8. Asia-Pacific Pharmaceutical Dissolution Testing Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Services Method
  • 8.2.2. By Dissolution Apparatus
  • 8.2.3. By Dosage Form
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pharmaceutical Dissolution Testing Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Services Method
      • 8.3.1.2.2. By Dissolution Apparatus
      • 8.3.1.2.3. By Dosage Form
  • 8.3.2. India Pharmaceutical Dissolution Testing Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Services Method
      • 8.3.2.2.2. By Dissolution Apparatus
      • 8.3.2.2.3. By Dosage Form
  • 8.3.3. South Korea Pharmaceutical Dissolution Testing Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Services Method
      • 8.3.3.2.2. By Dissolution Apparatus
      • 8.3.3.2.3. By Dosage Form
  • 8.3.4. Japan Pharmaceutical Dissolution Testing Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Services Method
      • 8.3.4.2.2. By Dissolution Apparatus
      • 8.3.4.2.3. By Dosage Form
  • 8.3.5. Australia Pharmaceutical Dissolution Testing Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Services Method
      • 8.3.5.2.2. By Dissolution Apparatus
      • 8.3.5.2.3. By Dosage Form

9. South America Pharmaceutical Dissolution Testing Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Services Method
  • 9.2.2. By Dissolution Apparatus
  • 9.2.3. By Dosage Form
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pharmaceutical Dissolution Testing Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Services Method
      • 9.3.1.2.2. By Dissolution Apparatus
      • 9.3.1.2.3. By Dosage Form
  • 9.3.2. Argentina Pharmaceutical Dissolution Testing Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Services Method
      • 9.3.2.2.2. By Dissolution Apparatus
      • 9.3.2.2.3. By Dosage Form
  • 9.3.3. Colombia Pharmaceutical Dissolution Testing Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Services Method
      • 9.3.3.2.2. By Dissolution Apparatus
      • 9.3.3.2.3. By Dosage Form

10. Middle East and Africa Pharmaceutical Dissolution Testing Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Services Method
  • 10.2.2. By Dissolution Apparatus
  • 10.2.3. By Dosage Form
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pharmaceutical Dissolution Testing Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Services Method
      • 10.3.1.2.2. By Dissolution Apparatus
      • 10.3.1.2.3. By Dosage Form
  • 10.3.2. Saudi Arabia Pharmaceutical Dissolution Testing Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Services Method
      • 10.3.2.2.2. By Dissolution Apparatus
      • 10.3.2.2.3. By Dosage Form
  • 10.3.3. UAE Pharmaceutical Dissolution Testing Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Services Method
      • 10.3.3.2.2. By Dissolution Apparatus
      • 10.3.3.2.3. By Dosage Form

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Intertek Group Plc
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Avivia BV
• 15.3. Almac Group
• 15.4. Agilent Technologies, Inc.
• 15.5. Catalent, Inc.
• 15.6. Thermofisher Scientific Inc.
• 15.7. Charles River Laboratories
• 15.8. Cambrex
• 15.9. Boston Analytical
• 15.10. Pace Analytical Life Sciences

16. Strategic Recommendations

17. About Us & Disclaimer